Davis Aaron I.'s Form 4 filing
Odonate Therapeutics, Inc. (ODT) · filed Nov 19, 2021
- Accession no.
- 0000899243-21-045438
- Filed
- Nov 19, 2021
- Trade date
- Nov 17-19, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $2.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Aaron I.CIK 0001465914 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2021 | Common Stock | SSaleDisposed | −170,000 | $2.23F3 | −$379,100 | 475,756 | Direct | |
| Nov 17, 2021 | Common Stock | SSaleDisposed | −600,000 | $2.17F4 | −$1,302,000 | 5,007,086 | Indirect | |
| Nov 18, 2021 | Common Stock | SSaleDisposed | −250,000 | $1.95 | −$487,500 | 4,757,086 | Indirect | |
| Nov 19, 2021 | Common Stock | SSaleDisposed | −30,000 | $1.92F5 | −$57,600 | 445,756 | Direct | |
| Nov 19, 2021 | Common Stock | SSaleDisposed | −150,000 | $1.84 | −$276,000 | 4,607,086 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.97 to $2.95.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $2.0026 to $2.4018.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.84 to $1.96.
Referenced by the price of 1 transaction in Table I.